Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Tenofovir To Abacavir In Hiv-1-Infected Subjects With Loss Of Bone Mineral Density

NCT01153217 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: Switch from tenofovir to abacavir

Sponsor

Germans Trias i Pujol Hospital